![Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2022/jco.2022.40.issue-34/jco.21.01604/20221116/images/large/jco.21.01604t1.jpeg)
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
![OS From the Phase 3 POLO Trial: Maintenance Olaparib for Germline BRCAm Metastatic Pancreatic Cancer | VuMedi OS From the Phase 3 POLO Trial: Maintenance Olaparib for Germline BRCAm Metastatic Pancreatic Cancer | VuMedi](http://media.vumedi.com/thumbs/video/2022/4/e58bae58-2bce-4635-954e-5d347520db81.300x170_q85_crop-smart_upscale.jpg)
OS From the Phase 3 POLO Trial: Maintenance Olaparib for Germline BRCAm Metastatic Pancreatic Cancer | VuMedi
![Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post](https://ascopost.com/media/14020567/3_kindler.jpeg?anchor=center&mode=crop&width=400&height=300&rnd=133035115490000000)
Maintenance Olaparib vs Placebo in Germline BRCA-Mutated Metastatic Pancreatic Cancer - The ASCO Post
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer on Vimeo
![Thomas George MD, FACP on X: "O'Reilly: If you have #PancreaticCancer, know your MSI and BRCA status! It could significantly change your treatment plan. #ASCO18 #PancSM https://t.co/kXXTaDdfCx" / X Thomas George MD, FACP on X: "O'Reilly: If you have #PancreaticCancer, know your MSI and BRCA status! It could significantly change your treatment plan. #ASCO18 #PancSM https://t.co/kXXTaDdfCx" / X](https://pbs.twimg.com/media/DeuElcyWsAAWsjC.jpg)